RLAYRelay Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 21022
Ticker: RLAY
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-07-16
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RLAY

Detail

Enriched 2026-08-14 20:47

Market cap: $4,398,172,534.17
Shares outstanding (class): 219,141,631
Shares outstanding (weighted): 219,141,631
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 192
Location: CAMBRIDGE, MA
Homepage: https://www.relaytx.com
Description: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Market cap and share counts drift.

Funds holding this security

97 funds · 98 positions · $210.94M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$57.05M	0.00%	5,734,147 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$34.31M	0.05%	3,448,477 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$28.17M	0.38%	2,831,639 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$14.61M	0.02%	1,468,118 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$12.93M	0.12%	1,299,962 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$12.03M	0.10%	1,208,852 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$9.75M	0.12%	980,266 NS	FIGI
Small Cap Value Fund Northern Funds	—	$3.94M	0.64%	396,435 NS	FIGI
JNL Multi-Manager Small Cap Value Fund JNL Series Trust	—	$3.80M	0.23%	382,228 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$2.67M	0.11%	268,048 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$2.28M	0.05%	229,429 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$2.13M	0.02%	214,353 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$1.98M	0.17%	198,563 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.88M	0.00%	189,180 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$1.74M	0.10%	174,567 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRLAY
FIGI_COMPOSITEBBG00DSS08K9
FIGI_SHARE_CLASSBBG00DSS08L8
CIK0001812364
ISINUS75943R1023
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Relay Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.